X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3279) 3279
Publication (249) 249
Book Review (22) 22
Conference Proceeding (17) 17
Book Chapter (8) 8
Book / eBook (3) 3
Magazine Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3069) 3069
male (2065) 2065
female (1893) 1893
middle aged (1797) 1797
esophagogastric junction - pathology (1615) 1615
aged (1584) 1584
index medicus (1466) 1466
esophagogastric junction (1413) 1413
esophageal neoplasms - pathology (1385) 1385
adult (1226) 1226
surgery (1053) 1053
adenocarcinoma - pathology (1049) 1049
stomach neoplasms - pathology (997) 997
adenocarcinoma (895) 895
oncology (859) 859
cancer (844) 844
gastroenterology & hepatology (819) 819
esophageal neoplasms - surgery (673) 673
aged, 80 and over (665) 665
neoplasm staging (652) 652
treatment outcome (591) 591
esophageal cancer (577) 577
prognosis (577) 577
adenocarcinoma - surgery (560) 560
esophagogastric junction - surgery (560) 560
retrospective studies (527) 527
stomach neoplasms - surgery (493) 493
carcinoma (471) 471
chemotherapy (455) 455
esophageal neoplasms - mortality (411) 411
barrett esophagus - pathology (408) 408
esophagus (374) 374
adenocarcinoma - mortality (369) 369
medicine & public health (359) 359
follow-up studies (353) 353
stomach neoplasms - drug therapy (344) 344
survival rate (338) 338
antineoplastic combined chemotherapy protocols - therapeutic use (330) 330
pathology (321) 321
esophageal neoplasms - therapy (315) 315
esophagus - pathology (315) 315
esophageal neoplasms - drug therapy (313) 313
esophagectomy (313) 313
stomach neoplasms - mortality (303) 303
barretts-esophagus (301) 301
adenocarcinoma - drug therapy (300) 300
gastroesophageal junction (293) 293
biopsy (290) 290
lymphatic metastasis (288) 288
analysis (287) 287
survival (284) 284
prospective studies (283) 283
gastric cancer (268) 268
care and treatment (262) 262
neoadjuvant therapy (258) 258
gastric cardia (254) 254
carcinoma, squamous cell - pathology (244) 244
intestinal metaplasia (242) 242
risk factors (242) 242
cardia (239) 239
diagnosis (239) 239
squamous-cell carcinoma (239) 239
survival analysis (239) 239
tumors (236) 236
esophagoscopy (235) 235
adenocarcinoma - therapy (233) 233
immunohistochemistry (226) 226
prevalence (224) 224
gastrectomy (221) 221
endoscopy (212) 212
gastroesophageal reflux - pathology (210) 210
cardia - pathology (209) 209
stomach cancer (209) 209
metaplasia (205) 205
barrett's esophagus (204) 204
metastasis (204) 204
research (202) 202
chemoradiotherapy (197) 197
combined modality therapy (197) 197
classification (196) 196
disease-free survival (195) 195
health aspects (193) 193
gastroenterology (192) 192
esophagectomy - methods (191) 191
esophageal neoplasms - diagnosis (190) 190
gastroesophageal reflux (189) 189
esophagogastric junction - physiopathology (188) 188
gastric mucosa - pathology (184) 184
gastric-cancer (176) 176
abridged index medicus (175) 175
adolescent (171) 171
adenocarcinoma - secondary (169) 169
dysplasia (168) 168
kaplan-meier estimate (162) 162
fluorouracil - administration & dosage (161) 161
stomach (159) 159
animals (158) 158
time factors (156) 156
therapy (154) 154
esophageal neoplasms - diagnostic imaging (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2972) 2972
German (80) 80
Japanese (60) 60
Chinese (55) 55
French (32) 32
Italian (26) 26
Spanish (22) 22
Russian (19) 19
Polish (6) 6
Romanian (4) 4
Hungarian (3) 3
Portuguese (3) 3
Serbian (3) 3
Croatian (1) 1
Finnish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1224 - 1235
Summary Background VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | ONCOLOGY | BEVACIZUMAB | CLINICAL-TRIALS | GROWTH | 2ND-LINE CHEMOTHERAPY | OPEN-LABEL | 1ST-LINE THERAPY | COMBINATION | CANCER | III TRIAL | Confidence Intervals | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Dose-Response Relationship, Drug | Esophageal Neoplasms - mortality | Adult | Female | Remission Induction - methods | Paclitaxel - administration & dosage | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagogastric Junction - pathology | Paclitaxel - adverse effects | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Hospitals | Clinical trials | Monoclonal antibodies | Product development | Antineoplastic agents | Vascular endothelial growth factor | Esophageal cancer
Journal Article
Nature, ISSN 0028-0836, 10/2017, Volume 550, Issue 7677, pp. 529 - 533
Journal Article
by Shitara, Kohei and Özgüroğlu, Mustafa and Bang, Yung-Jue and Di Bartolomeo, Maria and Mandalà, Mario and Ryu, Min-Hee and Fornaro, Lorenzo and Olesiński, Tomasz and Caglevic, Christian and Chung, Hyun C and Chung, Hyun Cheol and Muro, Kei and Goekkurt, Eray and Mansoor, Wasat and McDermott, Raymond S and Shacham-Shmueli, Einat and Chen, Xinqun and Chen, Jen-Shi and Mayo, Carlos and Kang, S Peter and Ohtsu, Atsushi and Fuchs, Charles S and Lerzo, Guillermo and O'Connor, Juan Manuel and Mendez, Guillermo Ariel and Lynam, James and Tebbutt, Niall and Wong, Mark and Strickland, Andrew and Karapetis, Chris and Goldstein, David and Vasey, Paul and Van Laethem, Jean-Luc and Van Cutsem, Eric and Berry, Scott and Vincent, Mark and Muller, Bettina and Rey, Felipe and Zambrano, Angela and Guerra, Joaquin and Krogh, Merete and Baeksgaard, Lene and Yilmaz, Mette and Elme, Anneli and Magi, Andrus and Auvinen, Paivi and Alanko, Tuomo and Moehler, Markus and Kunzmann, Volker and Seufferlein, Thomas and Thuss-Patience, Peter and Hoehler, Thomas and Haag, Georg and Al-Batran, Salah-Eddin and Castro, Hugo and Lopez, Karla and Aguilar Vasquez, Mynor and Sandoval, Mario and Lam, Ka On and Cuffe, Sinead and Kelly, Cathy and Geva, Ravit and Hubert, Ayala and Beny, Alex and Brenner, Baruch and Giuseppe, Aprile and Falcone, Alfredo and Maiello, Evaristo and Passalacqua, Rodolfo and Montesarchio, Vincenzo and Hara, Hiroki and Chin, Keisho and Nishina, Tomohiro and Komatsu, Yoshito and Machida, Nozumo and Hironaka, Shuichi and Satoh, Taroh and Tamura, Takao and Sugimoto, Naotaoshi and Cho, Haruhiko and Omuro, Yashushi and Kato, Ken and Goto, Masahiro and Hyodo, Ichinosuke and Yoshida, Kazuhiro and Baba, Hideo and Esaki, Taito and Furuse, Junji and Wan Mohammed, Wan Zamaniah and Hernandez Hernandez, Carlos and Casas Garcia, Juan and Dominguez Andrade, Adriana and Clarke, Katriona and Hjortland, Geir and Glenjen, Nils and Kubiatowski, Tomasz and Jacek, Jassem and Wojtukiewicz, Marek and Lazarev, Sergey and Lancukhay, Yuri and ... and KEYNOTE-061 Investigators and KEYNOTE-061 investigators
The Lancet, ISSN 0140-6736, 07/2018, Volume 392, Issue 10142, pp. 123 - 133
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. 36 - 42
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 02/2015, Volume 13, Issue 2, pp. 194 - 227
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 13, pp. 1448 - 1454
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1090 - 1098
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2015, Volume 18, Issue 1, pp. 168 - 176
Journal Article
13.